{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:25:00Z","timestamp":1768465500876,"version":"3.49.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:00:00Z","timestamp":1563926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["PTDC\/SAU-INF\/28466\/2017"],"award-info":[{"award-number":["PTDC\/SAU-INF\/28466\/2017"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/100571\/2014"],"award-info":[{"award-number":["SFRH\/BD\/100571\/2014"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/131384\/2017"],"award-info":[{"award-number":["SFRH\/BD\/131384\/2017"]}]},{"name":"CIISA - Centro de Investiga\u00e7\u00e3o Interdisciplinar em Sanidade Animal","award":["UID\/CVT\/00276\/2019"],"award-info":[{"award-number":["UID\/CVT\/00276\/2019"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220000","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T17:39:17Z","timestamp":1563989957000},"page":"e0220000","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diabetic foot infections: Application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms"],"prefix":"10.1371","volume":"14","author":[{"given":"Raquel","family":"Santos","sequence":"first","affiliation":[]},{"given":"Diana","family":"Ruza","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Tavares","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3910-1525","authenticated-orcid":true,"given":"Manuela","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"ref1","article-title":"Global report on diabetes","year":"2016"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"BA Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/193229681100500636","article-title":"Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not","volume":"5","author":"DG Armstrong","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"18409","DOI":"10.3402\/dfa.v3i0.18409","article-title":"Diabetic foot infections: current concept review","volume":"3","author":"KB Hobizal","year":"2012","journal-title":"Diabet Foot Ankle"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diabres.2011.10.001","article-title":"Clinical and bacteriological survey of diabetic foot infections in Lisbon","volume":"95","author":"JJ Mendes","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"S1","key":"ref6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/dmrr.2699","article-title":"IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes","volume":"32","author":"BA Lipsky","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1464-5491.2003.00860.x","article-title":"Methicillin-resistant <italic>Staphylococcus aureus<\/italic> in the diabetic foot clinic: a worsening problem","volume":"20","author":"C Dang","year":"2003","journal-title":"Diabet Med"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of <italic>Staphylococcus aureus<\/italic>: epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"J Kluytmans","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: <italic>Staphylococcus aureus<\/italic> in the antibiotic era","volume":"7","author":"HF Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"23","key":"ref10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-016-0250-7","article-title":"Molecular typing, virulence traits and antimicrobial resistance of diabetic foot staphylococci","volume":"8","author":"C Mottola","year":"2016","journal-title":"J Biomed Sci"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s13410-016-0492-7","article-title":"Frequency of MRSA in diabetic foot infections","volume":"37","author":"MT Akhi","year":"2017","journal-title":"Int J Diab Dev Ctries"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1039\/b804469b","article-title":"Quorum sensing and bacterial biofilms","volume":"27","author":"JS Dickschat","year":"2010","journal-title":"Nat Prod Rep"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1351\/PAC-REC-10-12-04","article-title":"Terminology for biorelated polymers and applications (IUPAC Recomendations 2012)","volume":"84","author":"M Vert","year":"2012","journal-title":"Pure Appl Chem"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.dsx.2013.02.006","article-title":"The diabetic foot infections: bioflms and antimicrobial resistance","volume":"7","author":"A Malik","year":"2013","journal-title":"Diabetes Metab Syndr"},{"key":"ref15","first-page":"CD011038","article-title":"Topical antimicrobial agents for preventing and treating foot infections in people with diabetes (Protocol)","volume":"3","author":"BA Lipsky","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/AAC.02419-14","article-title":"Prevalence of chlorhexidine-resistant methicillin-resistant <italic>Staphylococcus aureus<\/italic> following prolonged exposure","volume":"58","author":"CD Schlett","year":"2014","journal-title":"Antimicrob Agents Chemoter"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.ajic.2013.05.002","article-title":"Chlorhexidine activity against bacterial biofilms","volume":"41","author":"PC Bonez","year":"2013","journal-title":"Am J Infect Control"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhin.2015.09.013","article-title":"Establishment of a multi-species biofilm model to evaluate chlorhexidine efficacy","volume":"92","author":"RE Touzel","year":"2016","journal-title":"J Hosp Infect"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.medmal.2006.10.001","article-title":"Management of diabetic foot infections","volume":"37","author":"C Chidiac","year":"2007","journal-title":"Med Mal Infect"},{"issue":"1","key":"ref20","first-page":"71","article-title":"Diabetic foot infection","volume":"78","author":"M. Bader","year":"2008","journal-title":"Am Fam Physician"},{"issue":"2","key":"ref21","first-page":"65","article-title":"P\u00e9 diab\u00e9tico","volume":"7","author":"N Duarte","year":"2011","journal-title":"Angiol Cir Vasc"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/antibiotics3040572","article-title":"Old and new glycopeptide antibiotics: Action and resistance","volume":"3","author":"E Binda","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/644732","article-title":"Topical antimicrobial therapy for treating chronic wounds","volume":"49","author":"BA Lipsky","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"RE Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action","volume":"281","author":"Y Rosenfeld","year":"2006","journal-title":"J Biol Chem"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.bbamem.2015.10.013","article-title":"Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria","volume":"1858","author":"G Batoni","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1099\/jmm.0.000329","article-title":"Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers <italic>Staphylococcus aureus<\/italic> isolates","volume":"65","author":"R Santos","year":"2016","journal-title":"J Med Microbiol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cclet.2016.10.001","article-title":"A perspective on general direction and challenges facing antimicrobial peptides","volume":"28","author":"M Zhu","year":"2017","journal-title":"Chinese Chem Lett"},{"key":"ref29","first-page":"178","article-title":"The challenges of antibiotic resistance in the development of new therapeutics. Book Series: Frontiers in Antimicrobial Agents","author":"S Santos","year":"2015"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00284-012-0268-3","article-title":"Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application","volume":"66","author":"NH O\u2019Driscoll","year":"2013","journal-title":"Curr Microbiol"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01180-12","article-title":"<italic>In vitro<\/italic> activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant <italic>Staphylococcus aureus<\/italic> biofilms","volume":"56","author":"E Mataraci","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12223-015-0401-3","article-title":"Polymicrobial biofilms by diabetic foot clinical isolates","volume":"61","author":"C Mottola","year":"2016","journal-title":"Folia Microbiol (Praha)"},{"key":"ref33","article-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; CLSI document M07-A10","year":"2015"},{"key":"ref34","article-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents; CLSI document M26-A","year":"1999"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jac\/dkl393","article-title":"Bactericidal agents in the treatment of MRSA infections\u2013the potential role of daptomycin","volume":"58","author":"GL French","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/524736","article-title":"Chlorhexidine: Expanding the armamentarium for infection control and prevention","volume":"46","author":"AM Milstone","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12968\/jowc.2008.17.3.28668","article-title":"Should chlorhexidine gluconate be used in wound cleansing?","volume":"17","author":"RC Main","year":"2008","journal-title":"J Wound Care"},{"issue":"1","key":"ref38","first-page":"49","article-title":"Evidence summary: Wound management\u2013Chlorhexidine","volume":"25","year":"2017","journal-title":"Wound Pract Res"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12866-016-0737-0","article-title":"Susceptibility patterns of <italic>Staphylococcus aureus<\/italic> biofilms in diabetic foot infections","volume":"16","author":"C Mottola","year":"2016","journal-title":"BMC Microbiol"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2015.03.023","article-title":"Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant <italic>Staphylococcus aureus<\/italic> (MuH MRSA)","volume":"82","author":"Q Liu","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1097\/CCM.0b013e31819ffe6d","article-title":"The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant <italic>Staphylococcus aureus<\/italic>, vancomycin-resistant <italic>Enterococcus<\/italic>, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial","volume":"37","author":"MW Climo","year":"2009","journal-title":"Crit Care Med"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0310057X0803600404","article-title":"Chlorhexidine\u2013Pharmacology and clinical applications","volume":"36","author":"KS Lim","year":"2008","journal-title":"Anaesth Intensive Care"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/CMR.12.1.147","article-title":"Antiseptics and disinfectants: Activity, action, and resistance","volume":"12","author":"G McDonnell","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3904\/kjim.2015.240","article-title":"The efficacy of daily chlorhexidine bathing for preventive healthcare-associated infections in adult intensive care units","volume":"31","author":"H Huang","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5301\/ijao.5000027","article-title":"Antibiotic-induced biofilm formation","volume":"34","author":"JB Kaplan","year":"2011","journal-title":"Int J Artif Organs"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1128\/AAC.00888-13","article-title":"Effects of bacteriocins on methicillin-resistant <italic>Staphylococcus aureus<\/italic> biofilm","volume":"57","author":"K Okuda","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"MR Yeaman","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"12","key":"ref48","first-page":"5063","article-title":"Safety of nisin (E 234) as a food additive in the light of new toxicological data and the proposed extension of use","volume":"15","author":"M Younes","year":"2017","journal-title":"EFSA Journal"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1074\/jbc.M006770200","article-title":"Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity","volume":"276","author":"I Wiedemann","year":"2011","journal-title":"J. Biol. Chem"},{"issue":"6","key":"ref50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"MA Kohanski","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"ref51","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/AAC.01642-08","article-title":"<italic>In vitro<\/italic> activities of telavancin and vancomycin against biofilm-producing <italic>Staphylococcus aureus<\/italic>, <italic>S<\/italic>. <italic>epidermidis<\/italic>, and <italic>Enterococcus faecalis<\/italic> strains","volume":"53","author":"KL LaPlante","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1099\/jmm.0.068130-0","article-title":"Aminoglycoside inhibition of <italic>Staphylococcus aureus<\/italic> biofilm formation is nutrient dependent","volume":"63","author":"MJ Henry-Stanley","year":"2014","journal-title":"J Med Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T18:07:24Z","timestamp":1590084444000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220000"}},"subtitle":[],"editor":[{"given":"Meghan Scobee","family":"Blackledge","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220000","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]}}}